Impacto del cribado y tratamiento del bajo flujo sistémico en la prevención de hemorragia intraventricular grave y/o muerte en el prematuro-Reference-Cited by-同舟云学术

Impacto del cribado y tratamiento del bajo flujo sistémico en la prevención de hemorragia intraventricular grave y/o muerte en el prematuro

Published:2018-12 Issue:6 Volume:89 Page:369-377
ISSN:1695-4033
Container-title:Anales de Pediatría
language:es
Short-container-title:Anales de Pediatría

Author:

Oulego Erroz Ignacio,Alonso Quintela Paula,Jiménez Gonzalez Aquilina,Terroba Seara Sandra,Rodríguez Blanco Silvia,Rosón Varas María,Castañón López Leticia

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference40 articles.

1. Circulatory management focusing on preventing intraventricular hemorrhage and pulmonary hemorrhage in preterm infants;Su;Pediatr Neonatol,2016

2. Cerebral autoregulation brain injury, and the transitioning premature infant;Vesoulis;Front Pediatr,2017

3. Cerebral oxygenation, superior vena cava flow severe intraventricular hemorrhage and mortality in 60 very low birth weight infants;Cerbo;Neonatology,2015

4. A review of superior vena cava flow measurement in the neonate by functional echocardiography;McGovern;Acta Paediatr,2017

5. Relationship between blood pressure and blood flow in newborn preterm infants;Groves;Arch Dis Child Fetal Neonatal Ed,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between early echocardiography screening of low systemic blood flow and intraventricular hemorrhage in preterm infants: a multicenter cohort study;Journal of Perinatology;2024-04-25

2. Association Between Early Echocardiography Screening and Intraventricular Hemorrhage in Preterm Infants: A Prospective Observational Multicenter Study;2023-12-20

3. NT-PROBNP as a screening tool for low-risk patent ductus arteriousus: a follow-up validation study;European Journal of Pediatrics;2023-09-29

4. Nt-probnp as a Screening for Low-risk Patent Ductus Arteriousus: a Follow-up Validation Study;2023-08-31